Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Its fourth-quarter adjusted EPS of $7.54 easily beat the consensus estimate of $6.98
Clinical studies reveal promising results about ALCs effects on cognitive disorders
Maximum tissue benefit sometimes occurs at moderate rather than maximum concentrations
Here, in an observational, retrospective cohort study, we compared the incidence of congestive heart failure (CHF) in adults living with obesity and diabetes without history of CHF (primary CHF) treated with BMS versus GLP-1RA
You May Also Like see all More from RX Corporation see all Frequently Bought Together see all The information provided herein is accurate, updated and complete as per the best practices of the Company
US$ 25.96
US$ 28.86
US$ 20.53
US$ 23.77
US$ 25.19
US$ 25.88
